Introduction
============

Although cerebral white matter hyperintensities (WMHs) are not rare in healthy elderly individuals, they are commonly associated with cognitive disorders, mood disorders, and impaired physical function \[[@b1-jos-2019-01844],[@b2-jos-2019-01844]\]. WMHs are usually sub-classified into periventricular WMH and deep WMH according to the "continuity to ventricle" rule \[[@b3-jos-2019-01844]\]. Periventricular and deep WMHs have been associated with different etiologies; periventricular WMH is due to hemodynamic insufficiency (hypoperfusion) \[[@b2-jos-2019-01844],[@b4-jos-2019-01844]-[@b7-jos-2019-01844]\], whereas deep WMH is due to small vessel diseases \[[@b2-jos-2019-01844],[@b8-jos-2019-01844]-[@b10-jos-2019-01844]\].

Hypertension can cause both cerebral hypoperfusion \[[@b11-jos-2019-01844]-[@b13-jos-2019-01844]\] and small vessel disease \[[@b14-jos-2019-01844],[@b15-jos-2019-01844]\] and has been associated with the presence and amount of both periventricular WMH \[[@b16-jos-2019-01844],[@b17-jos-2019-01844]\] and deep WMH \[[@b18-jos-2019-01844],[@b19-jos-2019-01844]\]. In hypertension, cerebral hypoperfusion is known to result from the increased vascular resistance and disturbed hemodynamic flow patterns \[[@b11-jos-2019-01844]-[@b13-jos-2019-01844],[@b20-jos-2019-01844],[@b21-jos-2019-01844]\], whereas the small vessel disease results from endothelial dysfunction of the blood-brain barrier \[[@b22-jos-2019-01844]\]. Recently, Divisón-Garrote et al. \[[@b23-jos-2019-01844]\] using the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring (ABPM) Registry, showed that hypotension is relatively common in patients with treated hypertension, particularly among elderly individuals. One in three elderly patients with treated hypertension attended in routine clinical practice was potentially at risk of having hypotension, and more than half of them had masked hypotension \[[@b23-jos-2019-01844]\]. Hypotension is also known to increase the risk of WMHs by inducing cerebral hypoperfusion \[[@b24-jos-2019-01844]\]. In the Cardiovascular Determinants of Dementia Study, both increases and decreases in the diastolic blood pressure (BP) were associated with an increased incidence of periventricular WMH in elderly patients without dementia.

Compared to the individuals without hypertension, those with hypertension may be more vulnerable to cerebral hypoperfusion because their upper and lower boundaries of cerebral autoregulation may be upshifted \[[@b25-jos-2019-01844]-[@b28-jos-2019-01844]\]. However, the effect of hypotension on cerebral WMHs in patients with treated hypertension has never been directly investigated. In this study, we compared the association of hypotension on cerebral WMHs between elderly individuals with controlled hypertension and those without hypertension.

Methods
=======

Participants
------------

This study was conducted as a part of the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD). The KLOSCAD is an ongoing, nationwide, population-based, prospective cohort study on cognitive aging and dementia in the elderly \[[@b29-jos-2019-01844]\]. In the KLOSCAD, 6,818 community-dwelling Koreans, aged 60 years or older, who were randomly sampled from 30 villages or towns across South Korea, completed the baseline assessment, which was conducted from November 2010 through October 2012. Among them, 505 cognitively normal participants without hypertension or with controlled hypertension who were enrolled from Yongin, Gyeonggi-do were included in the current study ([Table 1](#t1-jos-2019-01844){ref-type="table"}). We excluded the participants with any of the following conditions: cognitive disorders, including dementia and mild cognitive impairment (MCI); major neurologic and psychiatric disorders; substance use disorders; and cardiovascular diseases, including uncontrolled hypertension with an office-measured systolic BP over 140 mm Hg or diastolic BP over 90 mm Hg.

All participants or their legal guardians provided written informed consent for study participation. The study was approved by the Institutional Review Board of the Seoul National University Bundang Hospital, Korea.

Assessments
-----------

A trained research nurse measured the BP three times (at the beginning, middle, and at the end of the clinical assessment when the participants visited the hospital) over the participants' right arm brachial artery, in a sitting position, using a mercury sphygmomanometer (No. 300-V, Tanaka Sangyo Co. Ltd., Tokyo, Japan). To reduce bias, the mean value of the three measurements was used for the analysis.

According to the presence of controlled hypertension, we subclassified the participants into two groups: those with controlled hypertension (HT+) and those without a history of hypertension (HT--). According to the current office-measured systolic BP, we also sub-classified the participants into two groups: low systolic BP group (LSBP), comprising those with a current systolic BP of 110 mm Hg or below, and not-low systolic BP group (NSBP), comprising those with a current systolic BP above 110 mm Hg, but below 140 mm Hg. According to the current office-measured diastolic BP, we sub-classified the participants into the following two groups: low diastolic BP group (LDBP), comprising those with a current diastolic BP of 60 mm Hg or below, and not-low diastolic BP group (NDBP), comprising those with a current diastolic BP between 61 and 90 mm Hg.

Geriatric psychiatrists with expertise in dementia research performed face-to-face, standardized diagnostic interviews; physical and neurological examinations; laboratory tests, including complete blood counts, chemistry profiles, and serological tests for syphilis; echocardiography; and chest X-ray imaging, using the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K) Clinical Assessment Battery \[[@b30-jos-2019-01844]\] and the Korean version of the Mini International Neuropsychiatric Interview \[[@b31-jos-2019-01844]\]. A research neuropsychologist or a trained research nurse administered the CERAD-K Neuropsychological Assessment Battery \[[@b30-jos-2019-01844],[@b32-jos-2019-01844]\], Digit Span Test \[[@b33-jos-2019-01844]\], and Frontal Assessment Battery \[[@b34-jos-2019-01844]\] to each participant. All participants performed --1.0 SD of the age-, sex-, and education-adjusted norms for elderly Koreans on the Mini-Mental State Examination \[[@b35-jos-2019-01844]\]. A panel of four research geriatric psychiatrists confirmed the final diagnosis for each participant. We diagnosed dementia and other axis I mental disorders according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, for dementia \[[@b36-jos-2019-01844]\] and MCI, according to the consensus criteria proposed by the International Working Group on MCI \[[@b37-jos-2019-01844]\]. Participants were considered cognitively normal if they did not exhibit any evidence of cognitive impairment that altered their daily activities and were functioning independently in the community.

Magnetic resonance imaging acquisition and processing
-----------------------------------------------------

All participants underwent magnetic resonance imaging (MRI) on a 3.0 Tesla GE SIGNA Scanner (GE Healthcare, Milwaukee, WI, USA). The MRI protocol included the following sequences: T~1~ (acquired voxel size = 1.0 mm^3^ × 0.5 mm^3^ × 0.5 mm^3^, field of view = 240 mm × 240 mm, 175 × 240 × 240 matrix in the x-, y-, and z- dimensions, 1.0 mm sagittal slices with no interslice gap, echo time = 3.68 ms, repetition time = 25.0 ms, number of excitations = 1, and flip angle = 90°) and fluid-attenuated inversion recovery (FLAIR) (acquired voxel size = 0.5 mm^3^ × 0.5 mm^3^ × 3.0 mm^3^, field of view = 240 mm × 240 mm, acquisition axial plane matrix size = 256 mm × 256 mm, 3.0-mm axial slices thickness with no interslice gap, echo time = 160 ms, repetition time = 9,900 ms, number of excitations = 1, flip angle = 90°, and inversion time = 2,500 ms).

The major steps of WMH image processing were as follows: (1) we obtained T~1~-weighted magnetic resonance (MR) images in all participants and we applied a bias field correction (BC) using the Statistical Parametric Mapping software version 8 (SPM8, Wellcome Trust Centre for Neuroimaging, London, UK) to correct the low-frequency and to smooth the signal that corrupts the MR images; (2) we re-sliced the BC-T~1~-weighted MR images into isotropic voxels (1.0 mm^3^ × 1.0 mm^3^ × 1.0 mm^3^); (3) we used the in-house code of MATLAB 2014a (MATLAB and Statistics Toolbox Release 2014a, The MathWorks Inc., Natick, MA, USA) to spatially normalize the re-sliced BC-T~1~-weighted MR images to the Korean normal elderly brain template (KNE96) \[[@b38-jos-2019-01844]\] and to allow for an inter-individual ventricle extraction; (4) we used the fully automated in-house code of MATLAB 2014a to spatially normalize the native spaced FLAIR images to the International Consortium for Brain Mapping template (ICBM) \[[@b39-jos-2019-01844]\] and to allow for an inter-individual WMH segmentation \[[@b40-jos-2019-01844]\], and we calculated the total volume of the WMHs (V~WMH~); (5) we performed co-registration between the re-sliced BC-T~1~-weighted MR images and the segmented WMH image of the same participants; and (6) we further sub-classified the WMHs into periventricular and deep WMHs, and the relative volumes (V~PVWMH~ and V~DWMH~, respectively) were calculated according to the distance rule \[[@b2-jos-2019-01844],[@b4-jos-2019-01844]\], using the fully automated in-house code of MATLAB 2014a.

We estimated the intracranial volume (ICV) of each participant using the Freesurfer software version 5.3.0 (<http://surfer.nmr.mgh.harvard.edu>) and used it as a covariate to consider the individual intracranial size variation.

Statistical analysis
--------------------

We compared the continuous and categorical variables between the groups using Student\'s t-test and Pearson\'s chi-square test, respectively. We examined the association of controlled hypertension, systolic and diastolic hypotension, and their interactions on the V~WMH~, V~PVWMH~, and V~DWMH~ using analysis of variance (ANOVA) that computed the age, ICV, hyperlipidemia, diabetes mellitus (DM), number of antihypertensive medication and duration of hypertension as covariates. We analyzed the association of systolic hypotension on the V~PVWMH~ in the HT+ and HT-- groups separately, using ANOVA that computed the age, ICV, hyperlipidemia, DM, diastolic BP, number of antihypertensive medication and duration of hypertension as covariates.

For all analyses, we used the SPSS for Windows version 20.0 (IBM Co., Armonk, NY, USA), and considered a two-sided *P*-value less than 0.05 as statistically significant.

Results
=======

The subjects in the HT+ group were slightly older, more likely to have DM, and showed modestly higher systolic BP than did those in the HT-- group. The subjects in the HT+ group also had a larger V~WMH~, V~PVWMH~, and V~DWMH~ than did those in the HT--group. The subjects in the LSBP group were more likely to have hyperlipidemia than were those in the NSBP group. The blood urea nitrogen and creatinine were comparable between LSBP and NSBP group and between LDBP and NDBP group. LDBP group had longer duration of hypertension than those in NDBP group. In the LSBP and LDBP groups, V~WMH~, V~PVWMH~, and V~DWMH~ were comparable to those in the NSBP and NDBP groups, respectively, in the unadjusted analyses. The number of antihypertensive medication was also comparable between LSBP and NSBP groups and between LDBP and NDBP group ([Table 1](#t1-jos-2019-01844){ref-type="table"}).

In the analysis of covariance (ANCOVA) that adjusted for age, ICV, hyperlipidemia, DM, number of antihypertensive medication and duration of hypertension, systolic BP (F~1,492~=3.887, P=0.049) and its interaction with hypertension (F~1,492~=7.836, P=0.005) ([Table 2](#t2-jos-2019-01844){ref-type="table"}) were associated with larger V~PVWMH~, but not with the V~DWMH~ ([Table 2](#t2-jos-2019-01844){ref-type="table"}). When we analyzed the association of LSBP with the V~PVWMH~ in the HT+ and HT-- groups separately, LSBP was associated with the V~PVWMH~ in the HT+ group, but not in the HT-- group ([Table 3](#t3-jos-2019-01844){ref-type="table"}). In the HT+ group, the subjects in the LSBP group had approximately 1.7 times larger V~PVWMH~ than did those the NSBP group (F~1,248~=6.750, P=0.010) ([Table 3](#t3-jos-2019-01844){ref-type="table"}). However, in the HT-- group, the V~PVWMH~ was comparable between the LSBP and NSBP groups (F~1,243~=0.774, *P*=0.380) ([Table 3](#t3-jos-2019-01844){ref-type="table"}). In contrast to low systolic BP, low diastolic BP was not associated with the V~WMH~, V~PVWMH~, nor the V~DWMH~ ([Table 2](#t2-jos-2019-01844){ref-type="table"}).

Discussion
==========

This study revealed that lower systolic BP and its interaction with hypertension, though controlled, was associated with a larger V~PVWMH~ in the participants with controlled hypertension.

The association of hypertension and WMHs has been repeatedly reported in previous cross-sectional and prospective studies. In the Cardiovascular Determinants of Dementia (CASCADE) study, higher systolic BP was associated with more severe periventricular and deep WMHs \[[@b41-jos-2019-01844]\]. In the Epidemiology of Vascular Aging study, hypertension at baseline was associated with an increased risk of having severe WMHs at the 4-year follow-up evaluation \[[@b42-jos-2019-01844]\]. In the Rotterdam Scan Study, hypertension at baseline was associated with an increased risk of both periventricular and deep WMHs, particularly in the elderly \[[@b43-jos-2019-01844]\].

When hypertension was controlled, the risk of WMHs due to hypertension was also reduced \[[@b42-jos-2019-01844],[@b43-jos-2019-01844]\]. However, in the CASCADE study, the participants with poorly controlled hypertension were found to have a higher risk of WMHs than those with an untreated hypertension \[[@b41-jos-2019-01844]\], which may be in line with our observation that the periventricular WMH were larger in the participants with controlled hypertension who had a low systolic BP. More than 8% of the patients with treated hypertension were found to have a low systolic BP \[[@b44-jos-2019-01844]\]. Previous studies showed that hypotension alone can result cerebral hypoperfusion; however, a more severe cerebral hypoperfusion was observed in the participants with hypertension \[[@b12-jos-2019-01844]\], which, even if controlled, may cause by damaging the cerebral autoregulation \[[@b45-jos-2019-01844],[@b46-jos-2019-01844]\]. Cerebral autoregulation is the innate capacity of the cerebral vasculature to maintain a constant cerebral blood flow (CBF) \[[@b47-jos-2019-01844]\], which allows adequate blood supply to the brain to meet the ample metabolic demands \[[@b48-jos-2019-01844]\]. Cerebral autoregulation in normotensive individuals is relatively constant, maintaining a fixed range of mean arterial pressure (MAP) between 60 and 150 mm Hg \[[@b49-jos-2019-01844]\]. When the MAP is within this range, the blood flow is actively controlled by changes in the arteries. However, when the MAP is below or above this range, blood supply may not be properly maintained, inducing damage to the brain \[[@b48-jos-2019-01844]\]. Patients with hypertension were found to have upshifted upper and lower limits of cerebral autoregulation \[[@b25-jos-2019-01844],[@b26-jos-2019-01844]\] and a higher cerebrovascular resistance compared with the normotensive controls, despite their global resting CBF and cerebral oxygen consumption being comparable to those in the normotensive controls \[[@b50-jos-2019-01844]\].

In this study, low diastolic BP was not associated with the volumes of the periventricular nor deep WMHs, which is in line with the findings of previous research on the association of BPs on cerebral perfusion. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure reported that systolic BP is a more important vascular risk factor than diastolic BP in subjects aged over 50 years \[[@b51-jos-2019-01844]\]. Glodzik et al. \[[@b52-jos-2019-01844]\] found that the cortical and hippocampal blood flows were negatively associated with the systolic BP, but not with the diastolic BP. In addition, they found that the cortical and hippocampal blood flows decreased as the systolic BP decreased during a 2-year follow-up period, whereas the same were not influenced by the decrease of diastolic BP in the same period \[[@b52-jos-2019-01844]\]. However, the effect of low diastolic BP warrants further investigation because the number of the participants with low diastolic BP was only 33 in the current study. Furthermore, low diastolic BP, which has been repeatedly reported to increase the WMHs in previous research, was not associated with the V~WMH~ in both the HT-- and HT+ groups in the current study.

We defined LSBP as being below 110 mm Hg in the current study because several studies reported that a low systolic BP below 90 mm Hg lacked clinical sensitivity. Eastridge et al. \[[@b53-jos-2019-01844]\] have studied the relevance of systolic BP in the mortality rate among 81,134 participants. The baseline mortality of the participants was \<2.5%. However, with the systolic BP at 110 mm Hg, the slope of mortality rate increased and was 4.8% greater for every decrement of 10 mm Hg in the systolic BP \[[@b53-jos-2019-01844]\]. Edelman et al. \[[@b54-jos-2019-01844]\] reported that among patients with gastric, small bowel, and/or diaphragm injuries, the mortality was higher in those with an systolic BP below 110 mm Hg (5%) than in those with an systolic BP of 110 mm Hg or higher (1%). We also defined LDBP as being below 60 mm Hg. Guichard et al. \[[@b55-jos-2019-01844]\] investigated BP and heart failure in 5,376 elderly participants and found that isolated diastolic hypotension, which was defined as a diastolic BP below 60 mm Hg, was a significant independent risk factor for heart failure. In the Oxford Project to Investigate Memory and Aging (OPTIMA) study \[[@b56-jos-2019-01844]\], a low diastolic BP, defined as a diastolic BP below 60 mm Hg, was related to a faster cognitive decline among patients with Alzheimer\'s disease.

There are several limitations in the current study. First, this study had a cross-sectional design. Second, we did not conduct a 24-hour ambulatory BP monitoring in the current study despite that BP is highly dynamic. Third, our multivariable analyses may not have fully adjusted all potential factors that may confound the association of BP and WMHs. Further study needs to compensate variables that may affect the BP or WMHs. Fourth, whether the low systolic BP in the participants with controlled hypertension is attributable to overtreatment of the hypertension or to underlying structural or functional abnormalities that are associated with predisposition to WMHs cannot be definitively determined.

Conclusions
===========

This study provides the evidence that systolic hypotension, after hypertensive condition, may increase V~PVWMH~. It is not common to individuals without history of hypertension or normotensive individuals. Elderly individuals with hypertension on treatment may be at the higher risk of periventricular WMH if they suffer hypotension
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###### 

Demographic and clinical characteristics of the participants

  Characteristic                                                       All             cHT             cSBP            cDBP            Statistics^[\*](#tfn1-jos-2019-01844){ref-type="table-fn"}^                                                       
  -------------------------------------------------------------------- --------------- --------------- --------------- --------------- ------------------------------------------------------------- --------------- --------------- --------- --------- ---------
  Number                                                               505             257             248             85              420                                                           33              472                                 
  Age (yr)                                                             73.8±6.3        75.0±6.2        72.6±6.0        73.7±6.4        73.9±6.2                                                      75.8±6.0        73.7±6.3        \<0.001   0.866     0.059
  Female sex (%)                                                       60.0            61.5            58.5            60.0            60.0                                                          60.6            60.0            0.490     1.000     0.941
  ICV (cc)                                                             1,562.0±156.9   1,548.2±157.1   1,576.2±155.7   1,591.8±160.4   1,555.9±155.6                                                 1,594.4±160.8   1,559.7±156.5   0.045     0.055     0.220
  V~WMH~ (cc)                                                          11.7±16.7       13.7±18.4       9.5±14.5        14.6±21.1       11.1±15.7                                                     12.8±15.4       11.6±16.8       0.004     0.141     0.691
  V~PVWMH~ (cc)                                                        8.2±9.8         9.6±11.4        6.8±7.6         9.9±10.6        7.9±9.6                                                       9.3±9.0         8.1±9.9         0.001     0.081     0.504
  V~DWMH~ (cc)                                                         3.5±8.1         4.2±7.9         2.7±8.3         4.7±12.2        3.2±7.1                                                       3.5±6.8         3.5±8.2         0.042     0.263     0.991
  Diabetes mellitus (%)                                                20.6            26.5            14.5            20              20.7                                                          24.2            20.3            0.001     0.882     0.592
  Hyperlipidemia (%)                                                   35.8            38.1            34.3            25.9            37.9                                                          27.3            36.4            0.274     0.036     0.288
  BUN (mg/dL)^[†](#tfn2-jos-2019-01844){ref-type="table-fn"}^          16.1±6.0        16.8±6.9        15.5±4.8        16.1±6.4        16.2±5.9                                                      16.8±6.5        16.1±6.0        0.012     0.983     0.583
  Creatinine (mg/dL)^[†](#tfn2-jos-2019-01844){ref-type="table-fn"}^   0.9±0.3         0.9±0.3         0.8±0.2         0.8±0.3         0.9±0.3                                                       0.9±0.4         0.9±0.3         0.117     0.734     0.811
  Duration of hypertension (yr)                                        5.7±8.9         11.3±9.7        NA              5.1±10.1        5.8±8.6                                                       10.3±13.5       5.1±8.4         \-        0.562     0.003
  SBP (mm Hg)                                                          122.7±10.1      124.1±9.9       121.2±10.2      106.3±5.4       126.0±7.3                                                     106.2±10.0      123.8±9.1       0.001     \<0.001   \<0.001
  DBP (mm Hg)                                                          75.0±8.1        75.1±8.3        74.9±8.0        65.2±6.5        77.0±6.8                                                      57.6±3.5        76.2±6.8        0.718     \<0.001   \<0.001
  Anti-hypertensive medication (n)                                     0.8±0.9         1.5±0.8         NA              0.5±0.9         0.8±0.9                                                       1.0±1.1         0.8±0.9         \-        0.009     0.217

Values are presented as mean±standard deviation.

cHT, controlled hypertension; cSBP, current systolic blood pressure; cDBP, current diastolic blood pressure; HT+, controlled hypertension group; HT--, without history of hypertension; LSBP, low systolic blood pressure group; NSBP, not-low systolic blood pressure group; LDBP, low diastolic blood pressure group; NDBP, not-low diastolic blood pressure group; ICV, intracranial volume; V~wmh~, volume of total white matter hyperintensity; V~pvwmh~, volume of periventricular white matter hyperintensity; V~dwmh~, volume of deep white matter hyperintensity; BUN, blood urea nitrogen; NA, not applicable; SBP, systolic blood pressure; DBP, diastolic blood pressure.

Student t-test was used for continuous variables and chi-square test for categorical variable;

n=484.

###### 

Association between history of hypertension, current blood pressure group and its interaction on volume of cerebral white matter hyperintensities^[\*](#tfn3-jos-2019-01844){ref-type="table-fn"}^

  Variable                 V~WMH~   V~PVWMH~   V~DWMH~                   
  ------------------------ -------- ---------- --------- ------- ------- -------
  Hypertension             0.011    0.916      0.002     0.960   0.073   0.788
  SBP group                3.586    0.059      3.887     0.049   2.281   0.132
  DBP group                0.341    0.559      0.296     0.587   0.292   0.589
  SBP group×DBP group      3.497    0.062      3.747     0.053   2.257   0.134
  SBP group×Hypertension   5.788    0.016      7.836     0.005   2.489   0.115
  DBP group×Hypertension   1.168    0.280      2.414     0.121   0.136   0.713

V~wmh~, volume of total white matter hyperintensity; V~PVWMH~, volume of periventricular white matter hyperintensity; V~dwmh~, volume of deep white matter hyperintensity; SBP, systolic blood pressure; DBP, diastolic blood pressure.

Analysis of covariance adjusted for intracranial volume, age, hyperlipidemia, diabetes mellitus, number of antihypertensive medications and duration of hypertension as covariates; d.f=1,492.

###### 

Association of systolic blood pressure on the volume of periventricular white matter hyperintensity in participants with controlled hypertension and those without hypertension

  Variable             V~PVWMH~    Statistics^[\*](#tfn4-jos-2019-01844){ref-type="table-fn"}^                   
  -------------------- ----------- ------------------------------------------------------------- ------- ------- -------
  HT+ group (n=257)    15.2±13.3   8.8±11.0                                                      6.750   1,248   0.010
  HT-- group (n=248)   7.0±7.5     6.7±7.6                                                       0.774   1,243   0.380

Values are presented as mean±standard deviation (cc).

V~PVWMH~, volume of periventricular white matter hyperintensity; LSBP, low systolic blood pressure group; NSBP, not-low systolic blood pressure group; HT+, participants with controlled hypertension; HT--, participants without hypertension.

Analysis of covariance adjusted for intracranial volume, age, hyperlipidemia, diabetes mellitus, diastolic blood pressure, number of antihypertensive medications and duration of hypertension as covariates.
